Potential usefulness of DNA methylation as a risk marker for digestive cancer associated with inflammation

DNA methylation has been deeply involved in the development and progression of digestive cancer, while aberrant DNA methylation has also often been observed in aged and inflammatory digestive tissues. Helicobacter pylori-related chronic gastritis, ulcerative colitis, and hepatitis B virus- and hepatitis C virus-related chronic hepatitis, are significant risk factors for developing cancer. A number of studies have revealed the specific methylation patterns for specific tissue types. DNA methylation status is stably transmitted to daughter cells. Also, unlike genetic mutations, it is possible to detect very tiny amounts of methylated DNA among tissues. Therefore, the use of aberrant methylation as a marker could be applicable to risk estimation of cancer development. We discuss the potential usefulness of DNA methylation as a risk marker for inflammation-associated digestive cancer, especially with attempts on gastric cancer, ulcerative colitis-associated cancer, and hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.

[1]  L. Egan,et al.  Inflammation, DNA methylation and colitis-associated cancer. , 2012, Carcinogenesis.

[2]  H. Aburatani,et al.  Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. , 2011, Cancer research.

[3]  Kazuhide Yamamoto,et al.  DNA methylation of colon mucosa in ulcerative colitis patients: Correlation with inflammatory status , 2011, Inflammatory bowel diseases.

[4]  Helmut Neumann,et al.  Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. , 2011, World journal of gastroenterology.

[5]  Nayoung Kim,et al.  Genome‐Wide DNA Methylation Profiles in Noncancerous Gastric Mucosae with Regard to Helicobacter pylori Infection and the Presence of Gastric Cancer , 2011, Helicobacter.

[6]  Judy H. Cho,et al.  Recent insights into the genetics of inflammatory bowel disease. , 2011, Gastroenterology.

[7]  J. Cubiella,et al.  5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. , 2011, Gastroenterology.

[8]  C. Lees,et al.  Genetics of ulcerative colitis , 2011, Inflammatory bowel diseases.

[9]  Helmut Neumann,et al.  New endoscopic approaches in IBD. , 2011, World journal of gastroenterology.

[10]  M. Toyota,et al.  Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. , 2010, Carcinogenesis.

[11]  T. Smyrk,et al.  Methylation Status of Genes in Non-Neoplastic Mucosa From Patients With Ulcerative Colitis-Associated Colorectal Cancer , 2010, The American Journal of Gastroenterology.

[12]  H. Aburatani,et al.  Identification of genes preferentially methylated in hepatitis C virus‐related hepatocellular carcinoma , 2010, Cancer science.

[13]  Y. Nakagawa,et al.  Increased Number of CpG Island Hypermethylation in Tumor Suppressor Genes of Non-Neoplastic Gastric Mucosa Correlates with Higher Risk of Gastric Cancer , 2010, Digestion.

[14]  Y. Kondo.  Epigenetic Cross-Talk between DNA Methylation and Histone Modifications in Human Cancers , 2009, Yonsei medical journal.

[15]  Yi Guo,et al.  Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. , 2009, Gastroenterology.

[16]  Y. Nakagawa,et al.  Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis , 2009, European journal of gastroenterology & hepatology.

[17]  M. Tatematsu,et al.  DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: Its possible involvement in the formation of epigenetic field defect , 2009, International journal of cancer.

[18]  Y. Nakagawa,et al.  Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. , 2009, International journal of molecular medicine.

[19]  M. Karin,et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.

[20]  Ozge Canli,et al.  gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. , 2009, Cancer cell.

[21]  Y. Nakagawa,et al.  Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC) , 2009, Clinical and Experimental Medicine.

[22]  M. Toyota,et al.  DNA methylation and cancer pathways in gastrointestinal tumors. , 2008, Pharmacogenomics.

[23]  Seung-Oe Lim,et al.  Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. , 2008, Gastroenterology.

[24]  M. Toyota,et al.  LINE-1 Hypomethylation Is Associated with Increased CpG Island Methylation in Helicobacter pylori–Related Enlarged-Fold Gastritis , 2008, Cancer Epidemiology Biomarkers & Prevention.

[25]  Michael K. Wendt,et al.  Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. , 2008, Inflammatory bowel diseases.

[26]  C. Boland,et al.  Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma , 2008, Hepatology.

[27]  H. Tajiri,et al.  CpG Island Hypermethylation of Tumor‐Suppressor Genes in H. pylori‐Infected Non‐Neoplastic Gastric Mucosa Is Linked with Gastric Cancer Risk , 2008, Helicobacter.

[28]  T. Moriyama,et al.  Hypermethylation of p14ARF May Be Predictive of Colitic Cancer in Patients with Ulcerative Colitis , 2007 .

[29]  J. Issa,et al.  Age-Related DNA Methylation Changes in Normal Human Prostate Tissues , 2007, Clinical Cancer Research.

[30]  E. Yu,et al.  Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. , 2007, Gastroenterology.

[31]  J. Issa,et al.  Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. , 2007, Gastroenterology.

[32]  T. Ushijima.  Epigenetic field for cancerization. , 2007, Journal of biochemistry and molecular biology.

[33]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[34]  S. Boyault,et al.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets , 2007, Hepatology.

[35]  M. Feitelson.  Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. , 2006, Cancer letters.

[36]  Zongtao Yu,et al.  Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma , 2006, Molecular carcinogenesis.

[37]  M. Toyota,et al.  Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein–Barr virus , 2006, Cancer.

[38]  A. Kaneda,et al.  High Levels of Aberrant DNA Methylation in Helicobacter pylori–Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk , 2006, Clinical Cancer Research.

[39]  G. Tamura.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. , 2006, World journal of gastroenterology.

[40]  A. Terano,et al.  Prediction of Colorectal Neoplasia by Quantitative Methylation Analysis of Estrogen Receptor Gene in Nonneoplastic Epithelium from Patients with Ulcerative Colitis , 2005, Clinical Cancer Research.

[41]  M. Toyota,et al.  Epigenetic changes in solid and hematopoietic tumors. , 2005, Seminars in oncology.

[42]  T. Fujimori,et al.  Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis , 2005, Gut.

[43]  T. Ushijima,et al.  Aberrant methylations in cancer cells: Where do they come from? , 2005, Cancer science.

[44]  T. Ushijima,et al.  Detection and interpretation of altered methylation patterns in cancer cells , 2005, Nature Reviews Cancer.

[45]  A. Forbes,et al.  Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk , 2004, Gut.

[46]  S. Itzkowitz,et al.  Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[47]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[48]  W. Xiao,et al.  Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. , 2004, World journal of gastroenterology.

[49]  S. Leung,et al.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.

[50]  A. Riggs,et al.  Methylation and epigenetic fidelity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Hyeon Joo Lee,et al.  Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. , 2003, The American journal of pathology.

[52]  J. Herman,et al.  Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. , 2003, The American journal of pathology.

[53]  Julie S. Jurenka,et al.  Inflammatory bowel disease Part 1: ulcerative colitis--pathophysiology and conventional and alternative treatment options. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[54]  K A Baggerly,et al.  Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. , 2003, BioTechniques.

[55]  A. Kaneda,et al.  Fidelity of the methylation pattern and its variation in the genome. , 2003, Genome research.

[56]  Chien-Jen Chen,et al.  High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1–DNA adduct levels in human hepatocellular carcinoma , 2002, Molecular carcinogenesis.

[57]  Nita Ahuja,et al.  DNA methylation and environmental exposures in human hepatocellular carcinoma. , 2002, Journal of the National Cancer Institute.

[58]  W. Yeo,et al.  Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[59]  N. Sasaki,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[60]  A. Hada,et al.  Genetic and epigenetic events in human hepatocarcinogenesis (review) , 2001 .

[61]  P. Dickman,et al.  Family history as a risk factor for colorectal cancer in inflammatory bowel disease. , 2001, Gastroenterology.

[62]  N. Ahuja,et al.  Accelerated age-related CpG island methylation in ulcerative colitis. , 2001, Cancer research.

[63]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[64]  W. H. Kim,et al.  CpG island methylation in premalignant stages of gastric carcinoma. , 2001, Cancer research.

[65]  H Ishii,et al.  Expression of mRNA for DNA methyltransferases and methyl‐CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis , 2001, Hepatology.

[66]  J. Satsangi,et al.  Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? , 2001, Gut.

[67]  M. Toyota,et al.  Detection of hypermethylation of thep16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus , 2001, Gut.

[68]  A. Gasbarrini,et al.  Microsatellite instability in Inflammatory Bowel Disease , 2000 .

[69]  N. Ahuja,et al.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[70]  S. Baylin,et al.  Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. , 1999, Cancer research.

[71]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Bar‐eli,et al.  Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[73]  S. Baylin,et al.  Aging and DNA methylation in colorectal mucosa and cancer. , 1998, Cancer research.

[74]  D. Schaid,et al.  Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. , 1998, Gastroenterology.

[75]  O. Hosokawa,et al.  Diagnosis of Gastric Cancer up to Three Years after Negative Upper Gastrointestinal Endoscopy , 1998, Endoscopy.

[76]  T. Toyota,et al.  Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease , 1998, Gut.

[77]  R. Hunt,et al.  Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. , 1998, Gastroenterology.

[78]  Y. Yamaoka,et al.  Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains , 1997, Gut.

[79]  K. Haruma,et al.  Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[80]  D. Wakefield,et al.  Expression of TNF‐α by human plasma cells in chronic inflammation , 1997, Journal of leukocyte biology.

[81]  S. Hirohashi,et al.  The E‐cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas , 1997, International journal of cancer.

[82]  Fred E. Silverstein,et al.  Helicobacter pylori in peptic ulcer disease. , 1994, NIH consensus statement.

[83]  M. Blaser,et al.  Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. , 1994, The Journal of clinical investigation.

[84]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[85]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[86]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[87]  神前 正幸.  Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colorectal tumors , 2012 .

[88]  김남규,et al.  DNA methylation predicts recurrence from resected stage III proximal colon cancer , 2011 .

[89]  J. Greally,et al.  Introduction to epigenomics and epigenome-wide analysis. , 2010, Methods in molecular biology.

[90]  T. Ushijima,et al.  Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication , 2009, Journal of Gastroenterology.

[91]  Makoto Watanabe,et al.  Aberrant DNA methylation in ulcerative colitis without neoplasia. , 2008, Hepato-gastroenterology.

[92]  J. Bruix,et al.  Novel advancements in the management of hepatocellular carcinoma in 2008. , 2008, Journal of hepatology.

[93]  山本 英一郎.  LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori-related enlarged fold gastritis , 2008 .

[94]  Y. Jeng,et al.  Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma , 2007, International journal of cancer.

[95]  T. Moriyama,et al.  Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis. , 2007, Diseases of the colon and rectum.

[96]  中島 健.  Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers , 2007 .

[97]  M. Gregor,et al.  Hypermethylation of the pl 6 INK 4 a Promoter in Colectomy Specimens of Patients with Long-standing and Extensive Ulcerative Colitis 1 ' 2 , 2006 .

[98]  M. Yamamoto,et al.  Genetic and epigenetic events in human hepatocarcinogenesis. , 2001, International journal of oncology.

[99]  岩田 徳和.  Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma , 2001 .

[100]  W. Lau,et al.  Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. , 1999, Cancer research.

[101]  T. Furuta,et al.  Relation between interleukin-1beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori. , 1999, Journal of gastroenterology.

[102]  S. Baylin,et al.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.

[103]  A. Ekbom.  Ulcerative Colitis and Colorectal Cancer , 1991 .